BioMerieux, Inc

PMN#

• VITEK 2 AST-Gram Positive Cefoxitin Screen

  2022-10-13

  BioMerieux, Inc

• VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 µg/mL)

  2022-04-14

  BioMerieux, Inc

• VITEK 2 AST-Gram Positive Linezolid (=8 µg/mL)

  2022-02-04

  BioMérieux, Inc

• VITEK 2 AST- Streptococcus Cefotaxime (8 Ug/mL)

  2021-10-28

  BioMerieux, Inc

• Vitek Densichek

  2019-10-31

  BioMerieux, Inc

• VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (=64/8 µg/mL)

  2019-02-26

  BioMerieux, Inc

• VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance

  2018-12-10

  BioMerieux, Inc

• Etest Ceftazidime/Avibactam (CZA) (0.016 - 256 Ug/mL)

  2017-09-15

  BioMerieux, Inc

• VITEK 2 AST-GN Ciprofloxacin (=4µg/mL)

  2017-06-21

  BioMerieux, Inc

• VITEK 2 AST-GN Gentamicin (=16 µg/mL)

  2017-03-13

  BioMerieux, Inc

• VIDAS B.R.A.H.M.S. PCT (PCT)

  2017-02-23

  BioMerieux, Inc

• VTEK 2 AST-GN Ceftolozane/Tazobactam (= 32 Mcg/mL)

  2017-02-13

  BIOMERIEUX, INC

• VITEK 2 AST-GN Cefepime (=32 Ug/mL)

  2016-07-20

  BIOMERIEUX, INC

• VIDAS B.R.A.H.M.S. PCT (PCT)

  2016-06-28

  BioMerieux, Inc

• VITEK 2 AST-Gram Negative Ertapenem (=8 Ug/mL)

  2016-04-15

  BioMerieux, Inc